![]() |
市場調査レポート
商品コード
1408043
メディカルツーリズムの世界市場の評価:サービス別、ステークホルダー別、ツアー別、消費者志向別、年齢層別、サービス提供者別、地域別、機会、予測(2017年~2031年)Global Medical Tourism Market Assessment, By Service, By Stakeholders, By Tour, By Consumer Orientation, By Age Group, By Service Provider, By Region, Opportunities and Forecast, 2017-2031F |
||||||
カスタマイズ可能
|
メディカルツーリズムの世界市場の評価:サービス別、ステークホルダー別、ツアー別、消費者志向別、年齢層別、サービス提供者別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年01月15日
発行: Market Xcel - Markets and Data
ページ情報: 英文 213 Pages
納期: 3~5営業日
|
世界のメディカルツーリズムの市場規模は、2023年に402億米ドル、2031年に1,306億2,000万米ドルに達し、2024年~2031年の予測期間にCAGRで15.87%の成長が見込まれています。市場の成長は、コスト削減、質の高い医療の提供、待ち時間の短縮、各国の二国間協定、アクセス性の向上、専門的な医療サービス、国際的な認定、患者の文化的/言語的選好との一致、観光地の魅力、包括的な保険範囲、政府の積極的な支援など、さまざまな影響力のある要因によるものと考えられます。
市場は、国境を越えた活気に満ちた急成長市場として台頭し、世界の医療情勢に大きな影響を与えています。費用対効果の高い医療ソリューションの追求が、メディカルツーリズムの急増を後押ししています。先進国の多くは医療費の高騰に対処しており、患者は多額の医療費と必要不可欠な治療のための長い待ち時間によって負担を強いられています。その結果、医療サービスの質が非常に高く、経済的にも実現可能な国への渡航という選択肢を模索する人々が増えており、メディカルツーリズムは魅力的で経済的にも賢明な選択肢となっています。
医療の質の重視も、市場の成長を支える重要な促進要因となっています。数多くのメディカルツーリズムの渡航先は、世界クラスの医療施設、国際的な認定を受けた病院、熟練した医療従事者を誇ります。患者は、専門的な医療処置、選択的手術、歯科治療、さらには臓器移植のような複雑な医療介入に向け、こうした渡航先を求めることが多いです。さらに、医療のグローバリゼーションは、交通インフラの改善、インターネットを通じた情報の入手性、医療提供者と観光事業者の国際的な協力関係の増大によって大いに促進され、世界市場を大きく促進しています。
価格の手頃さは、市場の拡大を促進する極めて重大な要因です。高額な医療制度を持つ国の患者は、自国内で特定の医療処置や治療を受ける際、しばしば経済的な制約に直面します。メディカルツーリズムは、魅力的で費用対効果の高い代替手段として機能しています。インド、タイ、メキシコなどの渡航先では、患者は国内で発生する費用よりもかなり低い費用で最高の医療サービスを受けることができます。価格の手頃さには、選択的手術、歯科治療、不妊治療、さらには心臓バイパス手術や臓器移植のような複雑な医療処置など、幅広い治療が含まれます。さらに、メディカルツーリズムの渡航先が提供する価格設定の透明性と競争力のある料金は、患者のメディカルツーリズムの計画を簡素化し、効果的な予算を可能にします。手頃な価格と質の高い医療の保証の融合は、海外で治療オプションを模索する人々にとって強力なインセンティブとなり、メディカルツーリズム産業の成長を後押ししています。
市場は、各国の二国間協定の流行により著しい成長を示しています。これらの協定は、医療施設における国境を越えた連携を促進し、患者の海外医療サービスへのアクセスを容易にします。二国間協定には通常、ビザ手続きの合理化、行政上の障害の軽減、医療資格の相互承認などが含まれ、外国で治療を受ける患者の手続きを簡素化します。このような取り決めは患者の信頼を高め、医療提供者の活動範囲を広げ、結果として患者の流入が増え、収益が増加します。このような各国の協力体制は、世界のメディカルツーリズム産業の拡大を後押しし、アクセス性を推進し、国境を越えたシームレスな医療サービスの提供を可能にします。
海外に医療サービスを求める人々によって特徴づけられる新興市場である世界のメディカルツーリズム市場の推進において、世界各国の政府は重要な役割を担っています。政府は患者のウェルビーイングと卓越した医療を保証するガイドラインや水準を設定することで、大きな影響力を発揮します。さらに政府は、自国を人気の高い医療渡航先として売り込むために、医療提供者と観光事業者のパートナーシップを奨励することができます。さらに、税制上のインセンティブや財政支援といった誘致策を提供することで、世界の患者を引き込み、経済成長を促進することもできます。メディカルツーリズムがしやすい環境を整備することで、政府は医療インフラの成長を促し、雇用機会を創出し、信頼できる医療ハブとしての評判を高め、ひいては患者にも経済にも利益をもたらすことができます。
当レポートでは、世界のメディカルツーリズム市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。
Global medical tourism market size was valued at USD 40.2 billion in 2023, expected to reach USD 130.62 billion in 2031, with a CAGR of 15.87% for the forecast period between 2024 and 2031F. The growth of the global medical tourism market is attributable to various influential factors, including cost savings, availability of quality healthcare, decreased waiting time, bilateral agreement between countries, enhanced accessibility, specialized medical services, international accreditation, alignment with patients' cultural and linguistic preferences, allure of tourism destinations, comprehensive insurance coverage, and active government support.
The global medical tourism market has emerged as a vibrant and rapidly growing market that transcends national boundaries, exerting a profound influence on the global healthcare landscape. The pursuit of cost-effective healthcare solutions fuels the surge in medical tourism. Many developed nations are dealing with soaring healthcare expenses, leaving patients burdened by huge amount of medical bills and long waiting time for essential treatments. Consequently, an increasing number of individuals are exploring the option of traveling to countries where medical services are of exceptional quality and financially feasible, rendering medical tourism an appealing and economically prudent choice.
The emphasis on the quality of healthcare is another pivotal driver behind the growth of global medical tourism market. Numerous medical tourism destinations proudly showcase world-class healthcare facilities, hospitals holding international accreditation, and a cadre of highly proficient medical practitioners. Patients often seek out these destinations for specialized medical procedures, elective surgeries, dental care, and even intricate medical interventions such as organ transplants. Furthermore, the globalization of healthcare has been greatly facilitated by improvements in transportation infrastructure, the accessibility of information through the internet, and increasing collaboration on an international scale between healthcare providers and tourism entities, significantly driving the global medical tourism market.
Affordability is a pivotal force driving the expansion of the global medical tourism market. Patients hailing from countries with costly healthcare systems frequently encounter financial constraints when seeking specific medical procedures or therapies within their home nations. Medical tourism serves as an attractive, cost-effective alternative. In destinations such as India, Thailand, and Mexico, patients can access the best healthcare services at considerably lower costs than those incurred domestically. Affordability encompasses a broad spectrum of medical treatments, spanning elective surgeries, dental interventions, fertility treatments, and even intricate medical procedures like heart bypass surgeries or organ transplants. Moreover, the transparency in pricing and competitive rates offered by medical tourism destinations simplifies the planning of patients' medical journeys and enables them to budget effectively. The fusion of affordability and a guarantee of high-quality care serves as a potent incentive for individuals exploring healthcare options abroad, thereby propelling the growth of the medical tourism industry.
The global medical tourism market is witnessing remarkable growth due to the increasing prevalence of bilateral agreements between nations. These accords promote cross-border collaboration in healthcare facilities, facilitating patients' access to medical services abroad. Bilateral partnerships typically involve streamlined visa procedures, a reduction in administrative obstacles, and the mutual recognition of medical credentials, simplifying the process for patients seeking treatment in foreign countries. Such arrangements increase patient's trust and extends the reach of healthcare providers, resulting in higher patient influx and increased revenue. This cooperative framework among nations drives the expansion of the global medical tourism industry, promoting accessibility and enabling the seamless provision of healthcare services across borders. For instance, in March 2023, Badr Treatment Abroad, a division of the Badr Al Samaa Group of Hospitals specializing in both inbound and outbound medical tourism services, established a collaborative partnership with Thailand's Bumrungrad International Hospital to offer top-tier healthcare services to patients from Oman.
Governments worldwide hold considerable role in promoting global medical tourism market, an emerging market characterized by people seeking healthcare services overseas. They exert substantial influence by setting guidelines and benchmarks to guarantee patient well-being and care excellence. Additionally, governments can encourage partnerships between healthcare providers and tourism entities to market their nation as a sought-after medical destination. Moreover, they may provide enticements like tax incentives and financial support to draw global patients and drive their economic growth. Through nurturing a conducive environment for medical travel, governments can spur the growth of healthcare infrastructure, generate employment opportunities, and bolster their reputation as a dependable healthcare hub, ultimately benefiting patients and their economy alike. In November 2021, Egypt's General Authority of Healthcare initiated its most extensive medical tourism campaign to endorse Luxor's hospitals. They entered into a collaborative agreement with a prominent domestic medical tourism firm, which will execute specialized medical programs across the authority's hospitals renowned for their top-tier treatment and accommodations.
The substantial expansion of the global medical tourism market is greatly attributed to the synergy of public-private partnerships (PPPs). These cooperative ventures between government bodies and private healthcare providers play a pivotal role in advancing the sector. Governments contribute by establishing regulatory frameworks, developing infrastructure, and promoting medical tourism, while private hospitals and clinics offer high-caliber healthcare services. The collaboration enhances the appeal of medical tourism destinations, ensuring they meet international standards and provide competitive pricing.
Such partnerships instill trust among patients, bolster the reputation of healthcare facilities, and significantly contribute to the growth of global medical tourism market. On October 7, 2023, the Tanzanian government and the Aga Khan Hospital jointly declared their commitment to strengthen their public-private partnership endeavors, working towards a shared objective of promoting medical tourism. The Aga Khan Hospital's exemplary infrastructure and facilities align seamlessly with the government's vision of positioning Tanzania as a leading medical tourism destination.
The surging need for cancer treatment is a pivotal factor driving the expansion of the global medical tourism market. The increasing worldwide incidence of cancer cases primarily drives the growing demand. As the prevalence of cancer continues to rise, patients are increasingly turning to renowned medical tourism destinations recognized for their state-of-the-art oncology treatments, innovative technologies, and top-tier medical proficiency. These destinations provide cost-effective alternatives and minimize waiting times, ensuring prompt and exceptional healthcare services. Consequently, the global medical tourism market is experiencing a notable increase in patients journeying abroad to access specialized cancer treatments, playing a significant role in its ongoing growth and development. To treat large inflow of patients, major hospital chains are adopting the best possible treatment methods.
In July 2022, Lunit, a prominent provider of medical AI solutions, revealed its partnership with FujiFilm Thailand and Microsoft to deliver AI-based cancer screening products to Bangkok's Bumrungrad International Hospital. The collaboration entails the deployment of Lunit INSIGHT CXR, an AI software for chest X-ray analysis with a CE mark, and Lunit INSIGHT MMG, an FDA-cleared AI solution for early-stage breast cancer detection, within Bumrungrad Hospital's facilities.
Countries such as UAE, Croatia, India, and Thailand are joining South Korea in their endeavor to become prominent medical tourism destinations. They prioritize providing exceptional healthcare for various treatments, including hip and knee surgery, bariatric surgery, cardiology, and gender reassignment procedures. The trend indicates a promising future for medical tourism. Medical tourism hubs, without compromising on care quality, are spearheading the transformation of healthcare services and contributing to national revenue growth. Whether it is a small Croatian town like Zabok specializing in orthopedic services or countries such as Spain, governments are actively meeting the rising demand in the sector and enhancing their medical tourism infrastructure. All these factors assure substantial growth of global medical tourism market in the future.
The global medical tourism market is witnessing a noticeable increase in collaboration among various stakeholders. Healthcare providers, governments, and tourism agencies are joining forces to elevate this industry. Hospitals partner with travel agencies to craft appealing medical tourism packages that blend healthcare services with travel opportunities. Governments are introducing policies and standards to ensure the quality of care and safety of patients, thereby attracting an international clientele.
In addition, insurance companies are developing specialized coverage for medical tourism, further stimulating market growth. Collaborative synergy broadens the market's reach and fosters a climate of trust, making medical tourism an increasingly viable choice for patients seeking top-notch care abroad.
For example, in December 2022, The Ascott Limited (Thailand), a wholly owned subsidiary of CapitaLand Investment specializing in lodging, and Bumrungrad International Hospital inked a memorandum of understanding (MOU). The MOU aims to deliver comprehensive privileges tailored to the requirements of patients, visitors, and those in search of medical care.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.